Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Neurology"
DOI: 10.1007/s00415-017-8658-x
Abstract: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic disease which can lead to many functional impairments, and like most other chronic disorders it might significantly affect quality of life (QoL). Information about QoL in patients…
read more here.
Keywords:
demyelinating polyradiculoneuropathy;
inflammatory demyelinating;
chronic inflammatory;
quality life ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "Acta Neurologica Belgica"
DOI: 10.1007/s13760-017-0836-1
Abstract: AbstractChronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired autoimmune demyelinating polyneuropathy characterized by symmetrical diffuse weakness that also can rarely affect bulbar and respiratory muscles. The study objective was to describe perioperative outcomes of patients…
read more here.
Keywords:
inflammatory demyelinating;
demyelinating polyradiculoneuropathy;
anesthesia;
chronic inflammatory ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Mayo Clinic Proceedings"
DOI: 10.1016/j.mayocp.2018.03.026
Abstract: &NA; Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is probably the best recognized progressive immune‐mediated peripheral neuropathy. It is characterized by a symmetrical, motor‐predominant peripheral neuropathy that produces both distal and proximal weakness. Large‐fiber abnormalities (weakness and…
read more here.
Keywords:
inflammatory demyelinating;
demyelinating polyradiculoneuropathy;
inflammatory;
chronic inflammatory ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2022.2169134
Abstract: ABSTRACT Introduction Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune peripheral nerve disorder that is characterized by subacute onset, progressive or relapsing weakness, and sensory deficits. Proven treatments include intravenous immunoglobulin (IVIg), corticosteroids, and plasma…
read more here.
Keywords:
cidp;
demyelinating polyradiculoneuropathy;
action;
mechanisms action ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Brain"
DOI: 10.1093/brain/awaa265
Abstract: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can be challenging to diagnose, and both under- and misdiagnosis are common. Eftimov et al. review the main diagnostic pitfalls associated with the various diagnostic modalities used in CIDP, and…
read more here.
Keywords:
inflammatory demyelinating;
demyelinating polyradiculoneuropathy;
diagnostic challenges;
chronic inflammatory ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Clinical Neuromuscular Disease"
DOI: 10.1097/cnd.0000000000000395
Abstract: Abstract Nodal/paranodal IgG4-related chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) rarely involves anticontactin (CNTN1) subtype and exceptionally complicates with nephrotic syndrome. A 65-year-old man developed weakness, facial palsy, and balance impairment; after spontaneous recovery, he severely relapsed…
read more here.
Keywords:
relapsing remitting;
demyelinating polyradiculoneuropathy;
membranous nephropathy;
inflammatory demyelinating ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical and Experimental Neuroimmunology"
DOI: 10.1111/cen3.12590
Abstract: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired immune‐mediated polyneuropathy characterized by relapsing or steadily progressive clinical course. A major feature of the syndrome is that it encompasses several pathogeneses, and it is actually assumed…
read more here.
Keywords:
inflammatory demyelinating;
patients igg4;
demyelinating polyradiculoneuropathy;
treatment ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "European Journal of Neurology"
DOI: 10.1111/ene.14501
Abstract: High peak serum immunoglobulin G (IgG) levels may not be needed for maintenance intravenous immunoglobulin (IVIg) treatment in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and such high levels may cause side effects. More frequent lower dosing…
read more here.
Keywords:
intravenous immunoglobulin;
inflammatory demyelinating;
demyelinating polyradiculoneuropathy;
maintenance ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2023 at "European Journal of Neurology"
DOI: 10.1111/ene.15693
Abstract: Tremor in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is underrecognized, and the pathophysiology remains incompletely understood. This study evaluated tremor in CIDP and tested the hypothesis, established in other demyelinating neuropathies, that tremor occurs due to…
read more here.
Keywords:
tremor;
polyradiculoneuropathy associated;
demyelinating polyradiculoneuropathy;
inflammatory demyelinating ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of the Peripheral Nervous System"
DOI: 10.1111/jns.12241
Abstract: Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and acute motor axonal neuropathy are the most common variants of Guillian‐Barre syndrome documented in the Asian population. However, the variability of early neurophysiologic findings in the Asian population compared…
read more here.
Keywords:
inflammatory demyelinating;
acute inflammatory;
demyelinating polyradiculoneuropathy;
barre syndrome ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of the Peripheral Nervous System"
DOI: 10.1111/jns.12242
Abstract: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients treated with intravenous immunoglobulin (IVIg) usually start with a standard dosage of 2 g/kg bodyweight. Only a minority of patients has a sustained improvement, and most require ongoing maintenance treatment.…
read more here.
Keywords:
inflammatory demyelinating;
maintenance treatment;
demyelinating polyradiculoneuropathy;
maintenance ... See more keywords